Edwards Lifesciences Corporation (EW) stock analysis
EW · Edwards Lifesciences Corporation
Latest recorded price: USD 107.12
Model-estimated fair value: USD 31.74. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $107.12, EW trades 237.4% above the model's base-case value of $31.74. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $27.17 in the conservative case and $36.89 in the optimistic case, with a valuation confidence score of 45/100. About 75% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 4.1%, free cash flow margin 22.0%, ROIC 15.9%. The model does not flag any risk signals for this company.
Similar companies in Healthcare
- GE HealthCare Technologies Inc. - Common Stock (GEHC)
- Glaukos Corporation Common Stock (GKOS)
- Globus Medical, Inc. (GMED)
- Haemonetics Corporation (HAE)
- Integra LifeSciences Holdings Corporation - Common Stock (IART)
- Inspire Medical Systems, Inc. Common Stock (INSP)
- iRadimed Corporation - Common Stock (IRMD)
- iRhythm Holdings, Inc. (IRTC)